Johnson & Johnson (NYSE:JNJ) will release earnings results for its third quarter before the opening bell on Tuesday, Oct. 15.

Analysts expect the New Brunswick, New Jersey-based bank to report quarterly earnings at $2.21 per share, down from $2.66 per share in the year-ago period. Johnson & Johnson projects to report revenue of $22.16 billion for the recent quarter, compared to $21.03 billion a year earlier, according to data from Benzinga Pro.

On Oct. 9, Johnson & Johnson said it has completed acquisition of V-Wave.

Johnson & Johnson shares gained 0.6% to close at $161.46 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

• Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $215 on Oct. 10. This analyst has an accuracy rate of 67%.
• TD Cowen analyst Joshua Jennings maintained a Buy rating and cut the price target from $195 to $185 on July 18. This analyst has an accuracy rate of 61%.
• Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and raised the price target from $167 to $169 on July 18. This analyst has an accuracy rate of 70%.
• B of A Securities analyst Geoff Meacham maintained a Neutral rating and cut the price target from $180 to $170 on April 17. This analyst has an accuracy rate of 61%.
• BMO Capital analyst James Fotheringham maintained a Market Perform rating and raised the price target from $57 to $59 on July 15. This analyst has an accuracy rate of 75%.

Considering buying JNJ stock? Here's what analysts think:

Read This Next:

• CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter